Postprandial hyperglycaemia - Its importance and implications

International Journal of Clinical Practice, Supplement

Volumn , Issue 104, 1999, Pages 3-7

  Lüddeke, Hans Joachim ^a  

^a Diabeteszentrum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

CONFERENCE PAPER; DIABETIC ANGIOPATHY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINA BLOOD FLOW; ACUTE DISEASE; BLOOD; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; REVIEW;

ACUTE DISEASE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; POSTPRANDIAL PERIOD;

EID: 33749224652     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Curtin A, Deegan P, Owens D et al. Elevated triglyceride-rich lipoproteins in diabetes: a study of apolipoprotein B-48. Acta Diabetol 1996; 33: 205-210.
2. Taskinen MR, Lahdenperä S, Syvänne M. New insights into lipid metabolism in non-insulin-dependent diabetes mellitus. Ann Med 1996, 28: 335-340.
3. Lamarche B, Tchernof A, Mauiege P et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961.
4. Lahdenperä S, Syvänne M, Kahri J, Taskinen MR. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 1996; 39: 453-461.
5. Picard F, Näimi N, Richard D, Deshaies Y. Response of adipose tissue lipoprotein lipase to the cephalic phase of insulin secretion. Diabetes 1999; 48: 452-459.
6. Ceriello A, Quatraro A, Giugliano D. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Med 1992; 9: 297-299.
7. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
8. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983.
9. Bursell S-E, Clermont AC, Kinsley BT et al. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 1996; 37: 886-897.
10. Schmetterer L, Woltz M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia 1999; 42: 387-405.
11. Grunwald JE, Bruckner AJ, Schwartz SS et al. Diabetic glycemic control and retinal blood flow. Diabetes 1990; 39: 602-607.
12. Skott P, Vaag A, Hother-Nielsen O et al. Effects of hyperglycemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dpendent diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 715-727.
13. Tuttle KR, Bruton JL, Perusek MC et al. Effect of strict glycemic control on renal haemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 1626-1632.
14. De Cosmo S, Earle K, Morocutti A et al. Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicylic acid infusion. Diabetologia 1993; 36: 622-627.
15. Takeuchi A, Throckmorton DC, Brogden AP et al. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiology 1995; 268: F13-F19.
16. Yeap BB, Russo A, Fraser RJ, Wittert GA, Horowitz M. Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care 1996; 19: 880-882.
17. Thye-Ronn R Sindrup SH, Arendt-Nielsen L et al. Effect of short-term hyperglycemia per se on nociceptive and non-nociceptive thresholds. Pain 1994; 56: 43-49.
18. Haffner S, Valdez R, Morales PA et al. Greater effect of glycemia on incidence of hypertension in women than in men. Diabetes Care 1992; 15: 1277-1284.
19. Ceriello A, Motz E, Cavarape A et al. Hyperglycaemia counterbalances the anti-hypertensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through oxidative stress in diabetes mellitus. J Diabet Compl 1997; 11: 250-255.
20. Tesfamarium B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991; 87: 1643-1648.
21. Ceriello A, Tobago C, Tonutti L et al. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia 1996; 39: 469-473
22. Ceriello A, Falleti E, Bartolotti N et al. Increased circulating ICAM-1 levels in type 2 diabetic patients. Metabolism 1996; 45: 498-501.
23. Haller H. Postprandial glucose and vascular disease. Diabet Med 1997; 14(Suppl 3): S50-S56.
24. Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21: 518-524.
25. Nagi DK, Pettitt DJ, Bennett PH et al. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM. Diabet Med 1997; 14: 449-456.
26. Chiasson JL, Gomis R, Hanefeld M et al. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance and normal glucose tolerance. Diabetes Care 1998; 21: 1664-1669.
27. Wasada T, Katsumori K, Saeki A, Saito S, Omori Y. Urinary albumin excretion rate is related to insulin resistance in normotensive subjects with impaired glucose tolerance. Diabetes Res Clin Pract 1997; 34: 157-162.
28. Nelson RG, Tan M, Beck GJ et al. Changing glomerular filtration with progression from impaired glucose tolerance to type II diabetes mellitus. Diabetologia 1999; 42: 90-93.
29. De Neeling JN, Beks PJ, Bertelsmann FW et al. Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 1996; 13: 960-966.
30. Brugger D, Lüddeke, H-J, Renner R, Hepp KD. Is impaired glucose tolerance associated with autonomic and peripheral neuropathy? Diabetologia 1998; 41(Suppl 1): A274. (abstract).
31. Erikson KF, Nilsson H, Lindgärde F et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 1994; 11: 279-285.
32. Burchfield CM, Shetterly SM, Baxter J, Hamman RF. The roles of insulin, obesity, and fat distribution in the elevation of cardiovascular risk factors in impaired glucose tolerance: the San Luis Valley Diabetes Study. Am J Epidemiol 1992; 136: 1101-1109.
33. Pan XR, Hu YH, Li GW et al. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese: Da Qing IGT and diabetes study. Diabetes Care 1993; 16: 150-156.
34. Lowe LR Liu K, Greenland P et al. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry study. Diabetes Care 1997; 20: 163-169.
35. Balkau B, Shipley M, Jarrett RJ et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall study, the Paris prospective study and the Helsinki policemen study. Diabetes Care 1998; 21: 360-367.
36. Wingard DL, Barrett-Connor EL, Scheidt-Nave C, McPhillips JB. Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM: a population based study. Diabetes Care 1993; 16: 1022-1025.
37. Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583.